NCT06740721View on ClinicalTrials.gov

False Lumen Treatment for Prevention of Aortic Growth Using Shape Memory Polymer - First-in-Human Study (FLAGSHIP_FRA)

NANot yet recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 5, 2026

Primary Completion Date

January 4, 2027

Study Completion Date

January 3, 2029

Conditions

Aortic Dissection

Interventions

DEVICE

False Lumen Embolization System, IMPEDE-FX RapidFill

Embolization of the false lumen of an aortic dissection

All Listed Sponsors

lead

Shape Memory Medical, Inc.

INDUSTRY

NCT06740721 - False Lumen Treatment for Prevention of Aortic Growth Using Shape Memory Polymer - First-in-Human Study (FLAGSHIP_FRA) | Biotech Hunter | Biotech Hunter